225 related articles for article (PubMed ID: 24824610)
1. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
2. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
[TBL] [Abstract][Full Text] [Related]
3. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.
Pajula K; Taskinen M; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2010 Jun; 7(3):795-804. PubMed ID: 20361760
[TBL] [Abstract][Full Text] [Related]
4. Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS.
Pajula K; Hyyryläinen J; Koistinen A; Leskinen JTT; Korhonen O
Eur J Pharm Biopharm; 2020 May; 150():43-49. PubMed ID: 32151730
[TBL] [Abstract][Full Text] [Related]
5. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Dependence of the Flory-Huggins Interaction Parameter on Temperature and Composition in a Drug-Polymer System.
Potter CB; Davis MT; Albadarin AB; Walker GM
Mol Pharm; 2018 Nov; 15(11):5327-5335. PubMed ID: 30259745
[TBL] [Abstract][Full Text] [Related]
7. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
8. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
Baghel S; Cathcart H; O'Reilly NJ
Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287
[TBL] [Abstract][Full Text] [Related]
9. Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy.
Kilpeläinen T; Ervasti T; Uurasjärvi E; Koistinen A; Ketolainen J; Korhonen O; Pajula K
Eur J Pharm Biopharm; 2022 Nov; 180():161-169. PubMed ID: 36122786
[TBL] [Abstract][Full Text] [Related]
10. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
Meng F; Dave V; Chauhan H
Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
[TBL] [Abstract][Full Text] [Related]
12. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
[TBL] [Abstract][Full Text] [Related]
13. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
14. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.
Marsac PJ; Li T; Taylor LS
Pharm Res; 2009 Jan; 26(1):139-51. PubMed ID: 18779927
[TBL] [Abstract][Full Text] [Related]
15. Molecular Dynamics and Physical Stability of Coamorphous Ezetimib and Indapamide Mixtures.
Knapik J; Wojnarowska Z; Grzybowska K; Jurkiewicz K; Tajber L; Paluch M
Mol Pharm; 2015 Oct; 12(10):3610-9. PubMed ID: 26301858
[TBL] [Abstract][Full Text] [Related]
16. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
[TBL] [Abstract][Full Text] [Related]
17. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
Abu-Diak OA; Jones DS; Andrews GP
J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
[TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory.
Bansal K; Baghel US; Thakral S
AAPS PharmSciTech; 2016 Apr; 17(2):318-27. PubMed ID: 26092302
[TBL] [Abstract][Full Text] [Related]
19. [The development of co-amorphous drug systems].
Yao J; Shi NQ; Wang XL
Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
[TBL] [Abstract][Full Text] [Related]
20. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
